Beyond Thinking
Welcome to Beyond Blue’s Thought Leadership Hub, where we highlight complex concepts with clarity and showcase our commitment to delivering excellence with ease. Explore our insights, discover innovative perspectives and join us on a journey to navigate the intricate with confidence.
AI in Market Research: Why we ranked it last in our own framework
Author: Sam Hope, CEO, Beyond Blue We just published a new whitepaper on AI in market research, specifically where it actually belongs in the insight ecosystem, and its impact on decision-making, and one part of it tends to surprise people: in our own framework, AI...
Putting the Work Into Workshops: Why the best positioning is built in the room
Author: Kristina DiPietrantonio, Head of Beyond Blue Strategy Division, Beyond Blue When positioning projects don't deliver the impact everyone hoped for, it's tempting to assume the positioning itself wasn't quite right. In my experience, that's rarely the real...
ESMO 2026: Our takeaways
Author: Siobhan Davies, Research Consultant, Oncology team @ Beyond Blue Personalized Cancer vaccines: A breakthrough brings a new learning curve A genuinely new modality requires building confidence in the science, the workflow, and what it means for patients, not...
5 Reasons Obesity is Rewriting the Demand Forecasting Playbook
Author: Stephanie Armstrong, Associate Director, Beyond Blue's CVRM team Forecasting demand is never easy. Teams are often required to make major portfolio, investment, and launch decisions years before a therapy reaches the market, in a landscape that may look very...
5 Tips to Get Pharma Market Research Right in the UAE & KSA: Before you even begin
Author: Rhona Chipanga, Research Executive, Beyond Blue There's a lot of opportunity in pharma research across the Gulf, but it only pays off if you understand how these markets actually work. Here are five things you might want to look out for if you are looking at...
The Power of Earlier: Transforming Alzheimer’s care
Authors: Nikita Shah & Nikita Walker, Beyond Blue Historically, Alzheimer's disease has been diagnosed once cognitive symptoms become noticeable and begin affecting daily life. By that stage, the underlying pathology of the disease may have been developing for...
The Most Dangerous Forecast is the One No One Challenges
Author: Sam Hope, CEO, Beyond Blue Demand forecasts have a habit of taking on a life of their own. A peak-share estimate, an uptake curve, a projected patient number – once it is written on a slide, it can start to feel more solid than it really is. Teams debate...
Defining the Behavior You Want to Change
Author: Rhona Auckland, Associate Director, Beyond Behavior, Beyond Blue Picture the scene, you’ve set clear strategic objectives, your market research partner has built in a behavioral science component, something like COM-B or EAST or the Health Belief Model. So,...
ASCO 2026: Key market shifts and considerations
Every year, ASCO stands as a defining moment in oncology research, and the 2026 meeting was no different. Our team has distilled the conference’s most significant market shifts and strategic imperatives, cutting through the volume to focus on what truly matters. Below...











